J Vet Sci.  2010 Jun;11(2):165-167. 10.4142/jvs.2010.11.2.165.

Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43

• Lee HK
• Lee BH
• Seok SH
• Baek MW
• Lee HY
• Kim DJ
• Na YR
• Noh KJ
• Park SH
• Kumar DN
• Kariwa H
• Nakauchi M
• Heo SJ
• Park JH

• KMID: 1110865
• DOI: http://doi.org/10.4142/jvs.2010.11.2.165

Abstract

Severe acute respiratory syndrome (SARS) is a life-threatening disease for which accurate diagnosis is essential. Although many tools have been developed for the diagnosis of SARS, false-positive reactions in negative sera may occur because of cross-reactivity with other coronaviruses. We have raised polyclonal and monoclonal antibodies (Abs) using a recombinant form of the SARS virus nucleocapsid protein. Cross-reactivity of these anti-SARS Abs against human coronavirus (HCoV) 229E and HCoV OC43 were determined by Western blotting. The Abs produced reacted with recombinant SARS virus nucleocapsid protein, but not with HCoV 229E or HCoV OC43.

Keyword

cross-reactivity; HCoV 229E; HCoV OC43; recombinant nucleocapsid protein; SARS

MeSH Terms

Antibodies, Viral/*immunology
Blotting, Western
Coronavirus 229E, Human/*immunology
Coronavirus OC43, Human/*immunology
Cross Reactions
Humans
Nucleocapsid Proteins/genetics/*immunology
Recombinant Proteins/immunology
SARS Virus/genetics/*immunology
Severe Acute Respiratory Syndrome/diagnosis/*immunology

Figure

• 

  Fig. 1 RT-PCR of cell lysates infected with human coronavirus (HCoV) 229E and HCoV OC43. A: HCoV 229E specific RT-PCR, B: HCoV OC43 specific RT-PCR. The results of RT-PCR were consistent with virally infected MRC-5 cell. Lane M: 100 bp DNA ladder, Lane MRC-5: normal MRC-5 cell lysates, Lane 229E: HCoV 229E infected MRC-5 cell lysates, Lane OC43: HCoV OC43 infected MRC-5 cell lysates.

• 

  Fig. 2 Western blotting for detecting cross reactivity of polyclonal antibody (Ab) and monoclonal Ab with HCoVs 229E and OC43. A: SDS-PAGE, B: reacted with polyclonal Ab, C: reacted with monoclonal Ab. Purified recombinant N protein (Lanes N), HCoV 229E infected cell lysates (Lanes 229E) and HCoV OC43 infected cell lysates (Lanes OC43) were run in SDS PAGE 12% gels with molecular weight markers in Lane M.

Reference

1. Che XY, Qiu LW, Pan YX, Wen K, Hao W, Zhang LY, Wang YD, Liao ZY, Hua X, Cheng VCC, Yuen KY. Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome. J Clin Microbiol. 2004. 42:2629–2635.

2. Fields BN, Knipe DM, Howley PM, Griffin DE. Fields' Virology. 2001. Philadelphia: Lippincott Williams & Wilkins;1163–1203.

3. He Q, Du Q, Lau S, Manopo I, Lu L, Chan SW, Fenner BJ, Kwang J. Characterization of monoclonal antibody against SARS coronavirus nucleocapsid antigen and development of an antigen capture ELISA. J Virol Methods. 2005. 127:46–53.

4. Lee HK, Lee BH, Dutta NK, Seok SH, Baek MW, Lee HY, Kim DJ, Na YR, Noh KJ, Park SH, Kariwa H, Nakauchi M, Mai LQ, Heo SJ, Park JH. Detection of antibodies against SARS-coronavirus using recombinant truncated nucleocapsid proteins by ELISA. J Microbiol Biotechnol. 2008. 18:1717–1721.

5. Peiris JSM, Chu CM, Cheng VCC, Chan KS, Hung IFN, Poon LLM, Law KI, Tang BSF, Hon TYW, Chan CS, Chan KH, Ng JSC, Zheng BJ, Ng WL, Lai RWM, Guan Y, Yuen KY. members of the HKU/UCH SARS Study Group. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003. 361:1767–1772.

6. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Peñaranda S, Bankamp B, Maher K, Chen MH, Tong S, Tamin A, Lowe L, Frace M, DeRisi JL, Chen Q, Wang D, Erdman DD, Peret TC, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rasmussen M, Fouchier R, Günther S, Osterhaus AD, Drosten C, Pallansch MA, Anderson LJ, Bellini WJ. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 2003. 300:1394–1399.

7. Shang B, Wang XY, Yuan JW, Vabret A, Wu XD, Yang RF, Tian L, Ji YY, Deubel V, Sun B. Characterization and application of monoclonal antibodies against N Protein of SARS-coronavirus. Biochem Biophys Res Commun. 2005. 336:110–117.

8. Shin GC, Chung YS, Kim IS, Cho HW, Kang C. Preparation and characterization of a novel monoclonal antibody specific to severe acute respiratory syndrome-coronavirus nucleocapsid protein. Virus Res. 2006. 122:109–118.

9. Sizun J, Yu MW, Talbot PJ. Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections. J Hosp Infect. 2000. 46:55–60.

10. Vabret A, Mouthon F, Mourez T, Gouarin S, Petitjean J, Freymuth F. Direct diagnosis of human respiratory coronaviruses 229E and OC43 by the polymerase chain reaction. J Virol Methods. 2001. 97:59–66.

11. van der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJ, Wolthers KC, Wertheim-vanDillen PM, Kaandorp J, Spaargaren J, Berkhout B. Identification of a new human coronavirus. Nat Med. 2004. 10:368–373.

12. Vlasova AN, Zhang X, Hasoksuz M, Nagesha HS, Haynes LM, Fang Y, Lu S, Saif LJ. Two-way antigenic cross-reactivity between severe acute respiratory syndrome coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the N-terminal region of the SARS-CoV nucleoprotein. J Virol. 2007. 81:13365–13377.

13. Woo PCY, Lau SKP, Chu CM, Chan KH, Tsoi HW, Huang Y, Wong BHL, Poon RWS, Cai JJ, Luk WK, Poon LLM, Wong SSY, Guan Y, Peiris JSM, Yuen KY. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol. 2005. 79:884–895.

14. Woo PCY, Lau SKP, Wong BHL, Chan KH, Hui WT, Kwan GSW, Peiris JSM, Couch RB, Yuen KY. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide. J Clin Microbiol. 2004. 42:5885–5888.